Loading...

VTVT VTV THERAPEUTICS INC US FDA Inspections 8-K Filing

VTV

VTVT

VTV THERAPEUTICS INC

(VTVT)

2025 8-K

Investor Update

Financial Results Announced

Investor Presentation Update

License Agreement Update

By-Law Amendment

Financial Results Release

Fireside Chat Announcement

Private Placement Agreement

Investor Meetings

Financial Statements

Investor Presentation

Financial Results

CFO Resignation

Investor Presentation

Financial Results

License Termination

Financial Results Announcement

Product Discontinuation

Agreement Amendment

Annual Meeting Results

Financial Results Announcement

Compliance regained with Na...

Appointment of Director

Financial Results Announcement

Investor Meetings

Sales Agreement with Cowen ...

Private Placement and Board...

Termination of License Agre...

Compliance with Minimum Bid...

Reverse Stock Split

Reverse Stock Split

Investor Conferences

Financial Results Announcement

Financial Results Announcement

Forced Delisting

Delisting Notice

Annual Meeting of Stockholders

Financial Results Announcement

Financial Results Announcement

Regulation FD Disclosure

External Links:

On March 17, 2025, vTv Therapeutics Inc. announced that the FDA has lifted the clinical hold on its Cadisegliatin program for diabetes, allowing the company to proceed with its clinical trials.

AI Assistant

VTV THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.